Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

The Botanicals Podcast

Dec 17 2021 | 00:13:40

00:00 / 00:13:40

Show Notes

Although adult-use sales of cannabis remain robust in U.S. states where it is legal, Nasdaq IR Intelligence analyst Saleem Daya sees continued stock underperformance across the Cannabis space going into year-end, building on activity in the second and third quarters of 2021.

Other Episodes

Episode 0

August 31, 2020 • 00:13:43

Chicago NORML: Social Equity Licenses Just the Start

Stephen Simpson, executive secretary of the cannabis advocacy group Chicago NORML, spoke with John Lothian News about the group's social equity agenda and why...

Episode 0

September 29, 2020 • 00:18:13

Cannabis sector outperforms S&P 500 as U.S. sales grow

Saleem Daya, analyst at Nasdaq corporate solutions in Toronto, updates John Lothian News on the Q2 performance of listed cannabis shares amid strong U.S....

Episode 0

July 21, 2021 • 00:20:20

Cannabis shares pull back in Q2 as U.S. regulatory momentum fizzles

Nasdaq IR Intelligence analyst Saleem Daya explains why the sector's heated year-end performance has cooled; cites rising yields, retail investor fatigue as action on...